Yongqiang Li
Shanghai University(CN)Ministry of Education of the People's Republic of China(CN)Zhejiang Normal University(CN)Guangxi Medical University(CN)Harbin Institute of Technology(CN)Shanghai Normal University(CN)Second Affiliated Hospital of Guangzhou Medical University(CN)Fudan University Shanghai Cancer Center(CN)Shanghai Genon Biological Products (China)(CN)Inner Mongolia Academy of Agricultural & Animal Husbandry Sciences(CN)Guangzhou First People's Hospital(CN)Air Force General Hospital PLA(CN)Heilongjiang Institute of Technology(CN)Nanjing Medical University(CN)South China University of Technology(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers, Liver Disease Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma(2019)246 cited
- → Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis(2018)164 cited
- → PB1-mediated virulence attenuation of H5N1 influenza virus in mice is associated with PB2(2011)52 cited
- → Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy(2017)52 cited
- → Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment(2021)49 cited
- → Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma(2024)39 cited